Skip to content
FolioFact
FolioFact
Q2 2026 7/58 funds filed
Newest stored record
Sign in Sign up

Polen Capital Management — TSHA

How Polen Capital Management's position in Taysha Gene Therapies Inc. changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing.

Quarters held
3
First reported
Q4 2025
Latest value
$3,331,581
Latest weight
0%
Peak weight
0%
Shares since first
+212.4%

Position Trend

Shares, value, and weight from first report to latest report.

Polen Capital Management first reported 156,586 shares in Q4 2025 and most recently reported 489,219 shares in Q2 2026. Portfolio weight peaked at 0% in Q2 2026; the low reported weight was 0% in Q4 2025.

Since the first report, shares are +212.4% and reported value is +286.8%. Latest move: ADD

Quarter Shares Value % of portfolio Change
Q2 2026 489,219 $3,331,581 0.03% ADD
Q1 2026 319,748 $1,429,274 0.01% ADD
Q4 2025 156,586 $861,223 0.0% NEW